Centaurus Therapeutics, Inc. — Form D
Centaurus Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-06-28. The offering totals $7.0M, of which $2.0M was reported sold. Industry: Other.
Offering
- Filed: 2022-06-28
- Form: D
- Accession: 0001935597-22-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $2.0M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2022-06-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-450491
Issuer
- Name: Centaurus Therapeutics, Inc.
- CIK: 0001935597
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1700 OWENS STREET, SUITE 515, SAN FRANCISCO, CA, 94158
- Phone: 415-606-8129
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Jeremy Blitzer | Director | San Francisco, CA |
| Stephen Halasz | Director | San Francisco, CA |
| Jeremy Blitzer | Executive Officer | San Francisco, CA |
| Stephen Halasz | Executive Officer | San Francisco, CA |
More